Welcome to Fleming Island Center for Clinical Research


Clinical trials move medicine forward. Sponsors, such as pharmaceutical companies, governments and foundations fund medical research. Patients who participate in clinical research receive many advantages including treatment at no cost, access to expertise and resources such as expensive tests. Research volunteers shape the future and can have fun while helping others and themselves.

 

As a premier clinical research organization, we have conducted more than 2,500 clinical trials over 20 years and have worldwide recognition for providing patients access to cutting edge medical research. If you have a medical issue and want a research solution, or if you are a healthy volunteer, come visit our center and learn more. One of our experts will be happy to evaluate you.


Shape the Future

Clinical research is a process that gives back. Volunteers generate information that improves future health care outcomes for everyone.

Find relief with new treatments

Volunteers join research to seek relief from affliction and to better understand their conditions with support from our caring team.

Programs Offer Resources or Pay

Study participants receive medical tests, services, counseling and treatment at no charge. These measures may be unavailable to the general public!


We do research in many areas


Statin Intolerance

Statin Intolerance Research Study


For more information call:

(904) 621-0390
email: cbuda@encoredocs.com 

 

Insomnia

Insomnia Research Study


 
For more information call:
(904) 621-0390
email: cbuda@encoredocs.com 





View all active studies

Our Volunteers Love Us


Watch what they have to say about their research experience!



Postpartum Depression Research Testimonial
Phase 1 Research Joe's Experience
Phase I Research Terry's Experience

Sign Up


I'm interested in... (Scroll to select multiple)






Our Staff

View All

Dr. Mitchell Rothstein

Dr. Mitchell Rothstein is a Clinical Research Investigator at our Fleming Island research site and he has been with us for 5 years now. In February 2017, we are happy to say that Dr. Rothstein also became our new Phase 1 Medical Director at our Jacksonville University research site. We consider him an all-star at ENCORE Research Group, not only did he perform the first endobronchial stent in Jacksonville, but he also lettered in gymnastics in college. Which is probably why he handles working at two locations with ease.

In his free time, he collects animation art, especially the work of Chuck Jones, the famous Looney Tunes animator. Dr. Rothstein is a major sports fan. He loves watching mixed martial arts and is an Olympics sports addict. He is also a fan of the Jacksonville Jaguars, the New York Mets and the Jacksonville Jumbo Shrimp, our minor-league baseball team in Jacksonville.

While Dr. Rothstein has some downtime, he enjoys eating, he calls himself a ‘happy carnivore’! Some of his favorite TV shows to watch are: Fargo, Billions, Jeopardy, and Snapped. All in all, we’re glad we have Dr. Rothstein as part of our ENCORE Research team and we’re excited to see what he accomplishes with us in the years to come. 

Lisa Moore

Do you know Lisa Moore at Fleming Island Center for Clinical Research?  She has been a member of our research family for fourteen years, and surprisingly in addition to being an accomplished research coordinator, she is a home project expert.  She can often be seen gardening and renovating her old house! 

Lisa is the mother of two children and a French bulldog mix. She enjoys health and fitness, and is currently a CrossFit devotee who also likes to compete in 5k runs.  This allows her to burn off her favorite foods which include cheese fondue with veggies and Renna’s pizza.

During those rare, quieter moments, you might find her at home baking, crafting or crocheting with her dog Sparkles by her side. 

Karen Schuran

“I LOVE to shop!  I would shop all the time if I could!” says Karen Schuran, who earns her shopping money by being the Research Assistant and Lab Processor at Fleming Island Center for Clinical Research. Karen has been a member of our research family for 10 years and continues to be a valuable asset to the company.
She and her husband are celebrating their 25th Anniversary of marriage this month. They have two children, a daughter and a son. Karen is also “Grandma” to a cute, fuzzy bunny named Snoopy.
Karen’s favorite sport is football, which she has been learning more about so she can keep up with the men in the house. She also likes to watch game shows like Wheel of Fortune and Jeopardy, but Karen admits her real guilty pleasure is horror movies. “I absolutely LOVE horror movies, the scarier the better!”

Lastest Blog Post:


"Pneumonia" the old man's friend

"Pneumonia" the old man's friend. The most frequent "sendoff" in the pre antibiotic era. In the US infectious disease remains a leading cause of death primarily due to pneumonia. Each year the bacteria Streptococcus pneumonia (pneumococcal) disease kills thousands of adults. It is spread from person to person through, coughing, sneezing and close contact. People can carry the bacteria in their throat, nose and sinuses and show no symptoms of infection and still spread the bacteria to people who do become ill. Illness can range from upper respiratory tract infections; sinus, ears and throat to much more severe disease (invasive pneumococcal disease, IPD) defined as pneumonia, blood stream infection and meningitis. There are dozens of different types of pneumococcus that vary by polysaccharides in the capsule that surrounds them. 
 
Vaccination against pneumococcal disease started in the pediatric age group and was quickly shown to be highly effective and then introduced to the adult population with similar results. It has been proven that vaccines against pneumococcus are safe and effective and DON'T CAUSE autism. Current recommendations are that adults 65 years old should receive 2 vaccines separated by at least one year. Re-vaccination with the same vaccine is generally not recommended.  PCV13 followed by PPSV23 after 1 year. The number on the vaccine tells you how many different types of pneumococcus are covered. Long term studies have shown a 75% reduction in IPD in adults after one dose of PCV13 or PPSV23 for the covered types and an overall 45% reduction against pneumococcal infections in general. Estimates for the U.S. project a vaccine related reduction of 3,000 deaths and 30,000 cases of IPD over the next 3 years.
 
Monitoring pneumococcal sub-types in the community allows us to produce more effective vaccines based on the sub-types identified. ENCORE Research Group is excited to participate in new pneumonia vaccine research! If you or someone you know may be interested in participating in our research, call our office to find out more! 

Pneumonia vaccine research is currently enrolling at:
Jacksonville Center for Clinical Research
Nature Coast Clinical Research – Crystal River
 
Written By:
Mitchell Rothstein, MD

View the full blog